+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cephalosporin Drugs Market - Global Forecast 2026-2032- Product Image
Cephalosporin Drugs Market - Global Forecast 2026-2032- Product Image
New

Cephalosporin Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 195 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011269
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cephalosporin drugs market is undergoing significant transformation as healthcare organizations globally respond to mounting challenges in antimicrobial stewardship, regulatory scrutiny, and supply chain complexity. Senior leaders benefit from understanding these market shifts to guide procurement, partnerships, and R&D priorities.

Market Snapshot: Cephalosporin Drugs Market Size and Growth Trends

The Cephalosporin Drugs Market expanded from USD 12.85 billion in 2025 to USD 13.63 billion in 2026 and is projected to maintain a compound annual growth rate (CAGR) of 6.97%, reaching USD 20.60 billion by 2032. This growth reflects shifting clinical demands, evolving resistance patterns, and intensifying efforts to diversify supply sources amid fluctuating policy environments.

Scope & Segmentation: Comprehensive Coverage of the Cephalosporin Drugs Market

  • Drug Class Generations: Fifth, Fourth, Third, Second, and First generation cephalosporins; notable third-generation agents include Cefdinir, Cefixime, Cefotaxime, Ceftazidime, and Ceftriaxone.
  • Routes of Administration: Intravenous and oral formulations, supporting both inpatient and outpatient care models.
  • Dosage Forms: Capsule, injection, powder, and tablet, each presenting distinct manufacturing and distribution requirements.
  • End Users: Hospitals, ambulatory surgical centers, homecare providers, and clinics, all with varied procurement and storage needs.
  • Distribution Channels: Offline and online channels influencing sales strategy and service delivery models.
  • Clinical Indications: Key therapeutic areas include respiratory tract infections (bronchitis, pneumonia), gonorrhea, sepsis, skin infections, and urinary tract infections.
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific—each with unique regulatory landscapes, payer models, and access dynamics.
  • Manufacturing Technologies: Emphasis on advanced process controls, digitalized quality systems, and sterile formulation capabilities across contract and in-house production.

Key Takeaways for Cephalosporin Drugs Market Stakeholders

  • Antimicrobial stewardship initiatives are evolving from siloed hospital programs to multi-institutional efforts, increasing demand for rapid diagnostic integration and driving more targeted cephalosporin use.
  • Geographic diversification of active pharmaceutical ingredient (API) sourcing is mitigating supply risks while digitalized manufacturing technologies enable greater process reliability and compliance.
  • Competitive dynamics are shifting as both innovators and generic manufacturers invest in improved quality systems, robust supply partnerships, and adaptive commercial strategies tailored to stakeholder needs.
  • End-user segmentation reveals rising relevance of homecare and ambulatory settings, redefining product and service delivery frameworks in alignment with new usage patterns.
  • Online distribution channels are gaining traction, especially for smaller providers, while traditional offline models remain central for high-volume hospital buyers.

Tariff Impact: Navigating Global Antibiotic Supply Challenges

United States tariff actions in 2025 altered sourcing economics and introduced new risks to antibiotic supply chains. Manufacturers responded by qualifying additional API suppliers, adapting contract terms, and reevaluating inventory management strategies. Procurement teams and payers have consequently revised frameworks to support supply assurance, leading to closer collaboration between regulators, distributors, and global partners to strengthen access and maintain quality standards.

Methodology & Data Sources

This report integrates primary interviews with pharmacists, clinicians, procurement and manufacturing leads, as well as extensive secondary research across regulatory filings, manufacturing databases, and trade records. Independent expert panels and triangulation methods validate findings for accuracy and practical relevance.

Why This Report Matters to Decision-Makers

  • Supports evidence-based procurement and sourcing policies to strengthen resilience amid global and regional supply pressures.
  • Enables alignment with the latest clinical guidance and antimicrobial stewardship standards to optimize therapeutic decision-making.
  • Informs investment and partnership strategies, targeting technology upgrades and diverse delivery models to address stakeholder-specific needs.

Conclusion

The cephalosporin drugs market is marked by rapid adaptation to clinical, regulatory, and operational shifts. Leaders equipped with timely research are better positioned to ensure continuity, manage risk, and support patient outcomes in a fast-evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cephalosporin Drugs Market, by Drug Class
8.1. Fifth Generation
8.2. First Generation
8.3. Fourth Generation
8.4. Second Generation
8.5. Third Generation
8.5.1. Cefdinir
8.5.2. Cefixime
8.5.3. Cefotaxime
8.5.4. Ceftazidime
8.5.5. Ceftriaxone
9. Cephalosporin Drugs Market, by Route Of Administration
9.1. Intravenous
9.2. Oral
10. Cephalosporin Drugs Market, by Dosage Form
10.1. Capsule
10.2. Injection
10.3. Powder
10.4. Tablet
11. Cephalosporin Drugs Market, by Application
11.1. Gonorrhea
11.2. Respiratory Tract Infections
11.2.1. Bronchitis
11.2.2. Pneumonia
11.3. Sepsis
11.4. Skin Infections
11.5. Urinary Tract Infections
12. Cephalosporin Drugs Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Clinics
12.3. Homecare
12.4. Hospitals
13. Cephalosporin Drugs Market, by Distribution Channel
13.1. Offline
13.2. Online
14. Cephalosporin Drugs Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Cephalosporin Drugs Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Cephalosporin Drugs Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Cephalosporin Drugs Market
18. China Cephalosporin Drugs Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories
19.6. Alkem Laboratories Ltd.
19.7. Astellas Pharma Inc.
19.8. AstraZeneca plc
19.9. Aurobindo Pharma Ltd.
19.10. Basilea Pharmaceutica Ltd.
19.11. Baxter International Inc.
19.12. Cipla Limited
19.13. CSPC Pharmaceutical Group Limited
19.14. Dhanuka Laboratories Ltd.
19.15. Fresenius Kabi AG
19.16. GlaxoSmithKline plc
19.17. Glenmark Pharmaceuticals Ltd.
19.18. Hikma Pharmaceuticals plc
19.19. Johnson & Johnson Services, Inc.
19.20. Lupin Limited
19.21. Merck & Co., Inc.
19.22. Novartis AG
19.23. Pfizer Inc.
19.24. Roche Holding AG
19.25. Sanofi S.A.
19.26. Shionogi & Co., Ltd.
19.27. Sun Pharmaceutical Industries Ltd.
19.28. Teva Pharmaceutical Industries Ltd.
19.29. Zydus Lifesciences Ltd.
List of Figures
FIGURE 1. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CEPHALOSPORIN DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CEPHALOSPORIN DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FIFTH GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FIFTH GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FIFTH GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FOURTH GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY FOURTH GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFDINIR, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFDINIR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFDINIR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFIXIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFIXIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFIXIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFOTAXIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFOTAXIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFOTAXIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFTAZIDIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFTAZIDIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFTAZIDIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFTRIAXONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFTRIAXONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CEFTRIAXONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY GONORRHEA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY GONORRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY PNEUMONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY PNEUMONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY PNEUMONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SEPSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SEPSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SEPSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SKIN INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY SKIN INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 137. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 139. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 155. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 156. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 157. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 159. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. AFRICA CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 173. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 174. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 175. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 176. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 178. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. ASEAN CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 182. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 183. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 185. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 187. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. GCC CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 200. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 201. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 203. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 205. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. BRICS CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 209. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 210. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 212. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 214. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. G7 CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 218. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 219. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 220. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 221. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 222. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 223. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. NATO CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL CEPHALOSPORIN DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 230. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 231. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 237. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY THIRD GENERATION, 2018-2032 (USD MILLION)
TABLE 238. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 240. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, 2018-2032 (USD MILLION)
TABLE 242. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. CHINA CEPHALOSPORIN DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cephalosporin Drugs market report include:
  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Aurobindo Pharma Ltd.
  • Basilea Pharmaceutica Ltd.
  • Baxter International Inc.
  • Cipla Limited
  • CSPC Pharmaceutical Group Limited
  • Dhanuka Laboratories Ltd.
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Hikma Pharmaceuticals plc
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages195
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.63 Billion
Forecasted Market Value ( USD ) by 2032 $ 20.6 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Chloromethyl Cephalosporin GCLE Market - Global Forecast 2026-2032 - Product Image

Chloromethyl Cephalosporin GCLE Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Cephalosporin Intermediates GCLE Market - Global Forecast 2026-2032 - Product Image

Cephalosporin Intermediates GCLE Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Cephalosporin Market Report by Generation, Route of Administration, Application, and Region ?2025-2033 - Product Image

Cephalosporin Market Report by Generation, Route of Administration, Application, and Region ?2025-2033

  • Report
  • 144 Pages
  • Global
From
Cephalosporin Drugs Market Report 2025 - Product Image

Cephalosporin Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Cephalosporin Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Cephalosporin Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Cephalosporins Market

Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from the fungus Cephalosporium and are closely related to penicillin. Cephalosporins are divided into four generations, each generation having a broader spectrum of activity than the previous one. They are used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. Cephalosporins are also used to treat some sexually transmitted diseases, such as gonorrhea. Cephalosporins are widely used in both human and veterinary medicine. They are available in a variety of formulations, including tablets, capsules, suspensions, and injections. Cephalosporins are generally well tolerated, with few side effects. Some companies in the Cephalosporins market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.